Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2020 Nov 3;60(2):937–945. doi: 10.1002/anie.202010280

Reactivity–Stereoselectivity Mapping for the Assembly of Mycobacterium marinum Lipooligosaccharides

Thomas Hansen 1,+, Tim P Ofman 1,+, Joey G C Vlaming 1,+, Ivan A Gagarinov 1, Jessey van Beek 1, Tessa A Goté 1, Jacoba M Tichem 1, Gijs Ruijgrok 1, Herman S Overkleeft 1, Dmitri V Filippov 1, Gijsbert A van der Marel 1, Jeroen D C Codée 1,
PMCID: PMC7821131  PMID: 32856761

Abstract

The assembly of complex bacterial glycans presenting rare structural motifs and cis‐glycosidic linkages is significantly obstructed by the lack of knowledge of the reactivity of the constituting building blocks and the stereoselectivity of the reactions in which they partake. We here report a strategy to map the reactivity of carbohydrate building blocks and apply it to understand the reactivity of the bacterial sugar, caryophyllose, a rare C12‐monosaccharide, containing a characteristic tetrasubstituted stereocenter. We mapped reactivity–stereoselectivity relationships for caryophyllose donor and acceptor glycosides by a systematic series of glycosylations in combination with the detection and characterization of different reactive intermediates using experimental and computational techniques. The insights garnered from these studies enabled the rational design of building blocks with the required properties to assemble mycobacterial lipooligosaccharide fragments of M. marinum.

Keywords: density functional calculations, glycosyl cation, glycosylation, reactivity, stereoselectivity


A joint experimental and computational approach was used to assess reactivity–stereoselectivity relationships of the bacterial sugar caryophyllose, a rare C12‐monosaccharide, containing a characteristic tetrasubstituted stereocenter. The fundamental insights gained guided the rational design of building blocks for the effective and stereoselective assembly of mycobacterial lipooligosaccharide fragments.

graphic file with name ANIE-60-937-g016.jpg

Introduction

The bacterial glycan repertoire is equally vast and diverse.[ 1 , 2 , 3 , 4 , 5 ] As opposed to the mammalian carbohydrate biosynthesis machinery that employs a limited set of 9 monosaccharides [6] to build oligosaccharides and glycoconjugates, the bacterial biomachinery can introduce a wide variety of substitution patterns.[ 1 , 2 , 3 , 4 , 5 ] Bacterial monosaccharides can feature diversely substituted amino groups, deoxy centers, carbonyl groups, and tetrasubstituted tertiary carbon atoms at various positions on the carbohydrate ring. Tertiary‐C sugars can be found in various natural products, having attractive biological properties.[ 7 , 8 , 9 , 10 ] Often these tertiary C‐atoms are substituted with a small alkyl group, commonly a methyl substituent, but more complex architectures in which functionalized alkyl chains are attached can be found as well. For example, the tertiary C‐sugar caryophyllose (Car, see Figure 1 A) is found in mycobacterial lipooligosaccharides (LOSs).[ 11 , 12 , 13 ] This unique structure bears a hydroxylated C6‐chain at the tetrasubstituted tertiary C4‐atom.

Figure 1.

Figure 1

Lipooligosaccharides from M. marinum and the target fragment with a retrosynthetic analysis. A) Tertiary C‐sugar caryophyllose (Car) found in mycobacterial lipooligosaccharides and the related yersiniose A (YerA). B) LOS‐IV from M. marinum. with numbering introduced by Rombouts et al.[ 11 , 12 , 13 ] C) Retrosynthetic analysis for LOS‐IV fragment 1.

The mycobacterial LOSs are major constituents of the thick and waxy cell wall of mycobacteria.[ 11 , 12 , 13 , 14 , 15 , 16 ] Being at the host–pathogen interface, they play an important role in the interaction with the immune system. Because it is exceedingly laborious to purify these lipophilic compounds from the bacterial cell wall, it has proven difficult to establish the precise role of these glycolipids in shaping an immune response. Mycobacterium marinum is a waterborne pathogen that is most closely related to Mycobacterium tuberculosis, and causes tuberculosis‐like infections. As such it is often used as a surrogate to study host‐pathogen interactions involved in M.tb infections. M. marinum produces four LOS structures (LOS‐I–IV; Figure 1 B), which all share an acylated trehalose core functionalized with species‐specific glycans. The LOS‐II, LOS‐III, and LOS‐IV structures of M. marinum contain several unusual carbohydrate monosaccharides, including the tertiary C‐sugar caryophyllose as well as an N‐acylated 4‐amino‐4‐deoxy‐d‐fucose (NAcFuc).[ 11 , 12 , 13 , 17 , 18 , 19 ] The complex carbohydrates of the higher LOS‐structures thus seem to play an important role in immune evasion although the exact mode of action of these remains ill‐understood.

The compelling bioactivity, intriguing structural features, and the fact that well‐defined pure LOS structures cannot be obtained from natural sources in sufficient amounts for biological studies motivated us to develop synthetic chemistry to attain these complex structures. Although great progress has been made in oligosaccharide synthesis, the assembly of bacterial glycans presenting rare structural modifications and challenging cis‐glycosidic linkages still presents a major obstacle as the reactivity of the required building blocks is not well understood.[ 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ] We here report an approach to map the reactivity–stereoselectivity relationships for the tertiary C‐sugar caryophyllose and its truncated counterpart yersiniose A (YerA; Figure 1 A). This has allowed us to effectively construct the Car‐Car‐NAcFuc LOS‐IV fragment 1 (Figure 1 C), and related shorter fragments, equipped with an alkene spacer for future conjugation purposes. The approach taken to understand the reactivity and stereoselectivity of these rare and challenging bacterial monosaccharides hinges on the detection and characterization of different reactive intermediates using experimental and computational techniques. These combined studies have enabled the rational design of building blocks with the desired reactivity and selectivity to assemble the spacer equipped LOS‐IV fragment 1 with complete stereoselectivity. Our study discloses the intrinsic reactivity of tertiary‐C Car donors, which can act as a prototype for related tertiary‐C sugars that can fuel biological research.

Results and Discussion

The Car‐Car‐NAcFuc carbohydrate 1 was assembled from the three key monomeric building blocks, pyrrolidone 2, 4‐amino‐4‐deoxy‐d‐fucose 3, and caryophyllose 4 (Figure 1 C). The design of the latter building block was based on reactivity studies, as outlined below. Pyrrolidone 2 can be synthesized based on the work of the Lowary group from d‐serine and the 4‐azido‐fucose donor 3 can be made from d‐glucose by deoxygenation of C6 and an inversion of the C4 position, following established procedures. [38] Car donor 4 can be synthesized from building blocks 5 and 6 by a SmI2‐mediated C−C bond formation, as originally described by Prandi and co‐workers.[ 39 , 40 ]

Our first goal was the generation of sufficient amounts of the Car donor glycosides, required to map the reactivity of these building blocks and build the target fragment 1. To this end acid chloride 5 and 2,6‐dideoxy‐4‐keto‐glucose 6 were assembled. The synthesis of 5 is depicted in Scheme 1 A and started from methyl‐α‐d‐glucopyranose. Epoxide 7 was readily prepared in three steps (>150 gram scale). Regioselective opening of the epoxide with LiAlH4 afforded digitoxose‐configured 8 in good yield (78 %, >120 gram scale). Installation of the temporary 2‐methylnaphthyl protecting group resulted in fully protected 9. The 4,6‐O‐benzylidene protecting group was removed using a catalytic amount of I2 to yield diol 10 (99 %), and the primary alcohol was converted into iodide 11 using triphenylphosphine, iodine, and imidazole. Radical reduction using NaBCNH3 and AIBN yielded the partially protected d‐digitoxose 12 (74 %, >100 gram scale). [41] Hydrolysis of d‐digitoxose 12 with 25 % v:v aq. AcOH, followed by the treatment with ethanethiol and concentrated HCl afforded the linear diethyl dithioacetal 13 (67 % over two steps, 50 gram scale). Subsequently, both hydroxyl functions of the dithioacetal were protected with a TBS group using TBSOTf and pyridine to yield the fully protected 14 (62 %).

Scheme 1.

Scheme 1

Synthesis of 4, 5, 6, 23, 24, and 25. A) Synthesis of building block 5. Reagents and conditions: (1) i. benzaldehyde dimethyl acetal, I2, CH3CN; ii. MsCl, pyridine; iii. KOH, THF/MeOH (55 % over three steps); (2) LiAlH4, Et2O (78 %); (3) NapBr, NaH, DMF (quant.); (4) I2, MeOH (99 %); (5) imidazole, triphenylphosphine, I2, toluene, 75 °C (66 %); (6) NaBCNH3, AIBN, t‐BuOH, 80 °C (74 %); (7) i. aq. 25 % AcOH, reflux; ii. EtSH, aq. 37 % HCl (67 % over 2 steps); (8) TBSOTf, pyridine, DCM (62 %); (9) I2, NaHCO3, acetone, H2O (81 %); (10) KMnO4 aq., NaH2PO4 aq., t‐BuOH (75 %); (11) (COCl)2, pyridine. B) Synthesis of donor 4 and 23. Reagents and conditions: (1) tribromoimidazole, triphenylphosphine, toluene, reflux (60 %); (2) AIBN, Bu3SnH, toluene, reflux (99 %); (3) i. tributyltin oxide, toluene, reflux; ii. benzyl bromide, reflux (31 %); (4) DMP, DCM (91 %); (5) SmI2, 5, THF, 50 °C, 15 min (82 %); (6) i. Zn(BH4)2, THF; ii. 6 M HCl, MeOH; iii. CDI, DCM (58 % over three steps); (7) Ac2O, H2SO4, 1 min (94 %); (8) thiophenol, BF3⋅OEt2, DCM (61 %). Pyr=pyridine, NapBr=2‐(bromomethyl)naphthalene, TBI=2,4,5‐tribromoimidazole, TBSOTf=t‐butyldimethylsilyl trifluoromethanesulfonate, TPP=triphenylphosphine, AIBN=azobisisobutyronitrile, DMP=Dess–Martin periodinane, CDI=carbonyldiimidazole.

Treating dithioacetal 14 with I2 and NaHCO3 in acetone/water delivered the corresponding aldehyde 15 in 81 % yield (30 gram scale). Oxidation with potassium permanganate in t‐BuOH/water of aldehyde 15 furnished the protected acid 16 (75 %), which could be converted to building block 5 with pyridine and oxalyl chloride.

As depicted in Scheme 1 B building block 6 was also synthesized from methyl‐α‐d‐glucopyranoside, starting with the regioselective bromination of the C3‐ and C6‐position using tribromoimidazole in good yield (60 %, >30 gram scale). Removal of the bromides using tributyltin hydride and AIBN afforded the required dideoxy glucoside 18 in excellent yield (99 %, 15 gram scale). The reaction of 18 with tributyltin oxide, followed by benzyl bromide provided the benzylated glucoside 19 in 31 % yield. Oxidation of the C4‐alcohol in 19 with Dess–Martin periodinane then afforded key building block 6 (90 %).

To build the tertiary C‐sugar having the required Car‐configuration, a SmI2‐promoted C−C bond coupling was employed using acyl chloride 5 and ketone 6 (Scheme 1 B). The best yield for this cross‐coupling was obtained by premixing both coupling partners and quickly adding them, by canula, to a warm (50 °C) solution of SmI2 in THF under completely inert atmosphere. This procedure reliably delivered ketone 20 with the required stereochemistry at C4 in 82 % yield (gram scale). A chelation controlled reduction of ketone 20 with Zn(BH4)2 in THF then afforded the free alcohol. After removal of the silyl protection groups and protection of the two vicinal diols using carbonyldiimidazole caryophyllose 21 was obtained in 58 % (over three steps, 15 gram scale). Proof for the stereochemistry of the C7 position was obtained by NOESY NMR experiments (See SI). The anomeric methoxy group of caryophyllose 21 was then converted to an acetyl group using H2SO4 in acetic anhydride. The anomeric acetate 22 was formed in excellent yield (94 %, >5 gram scale) and subsequently transformed into the key caryophyllose thioglycoside 4 under the aegis of thiophenol and BF3⋅OEt2. Following a highly similar route, the per‐O‐Bn caryophyllose thioglycoside 24 was constructed (See SI). We also assembled yersiniose A (YerA) donors 23 and 25, to be used as model donors to map the reactivity–selectivity of these type of donors (See SI).

With all donors in hand, we set out to study the glycosylation properties of the building blocks under pre‐activation conditions (Figure 2 A). To do so we first investigated the possible reactive intermediates that can play a role during the glycosylation of these donors. Covalent species, such as anomeric triflates are formed, which can undergo a SN2‐like substitution or serve as a reservoir for more reactive oxocarbenium ion type species that partake in substitution reactions with more SN1‐character. We started our investigation with the detection of the formation of reactive covalent species by the use of variable‐T NMR. [42] We first tested the per‐O‐benzyl donor 24. To this end a mixture of 24 and Ph2SO (1.3 equiv.) in CD2Cl2 was treated with Tf2O (1.3 equiv.) at −80 °C (Figure 2 B). [43] Directly after the addition, NMR data (1H, HSQC, COSY) were recorded, to reveal the generation of a single new species. The signals of the anomeric H and C atoms appeared at δ 4.7 ppm and δ 90.4 ppm for 1H and 13C respectively, which is significantly upfield from signals corresponding to an anomeric triflate or oxosulfonium triflate species (generally found at 1H: δ≈5–6.5 ppm and 13C: δ≈105–110 ppm).[ 42 , 44 , 45 , 46 , 47 ] Warming the sample did not lead to any degradation of the initially formed product, and therefore it could be isolated. NMR analysis (1H, 13C, HSQC, COSY, NOESY and HMBC) identified the formed species to be bicyclic compound 26. Similarly, upon activation of the structurally simpler yersiniose donor 25, a corresponding bicycle was formed. These bicycles are formed by nucleophilic attack, of the C7 benzyl ether oxygen atom, on the activated C1 position.

Figure 2.

Figure 2

Mapping the relevant reactive intermediates by a combined experimental and computational approach. A) The reaction mechanism continuum operational during glycosylation reactions. Glycosylation reactions are best considered as taking place at a continuum between two formal extremes of the mechanisms, including the SN1 and SN2 mechanism. B) Upon activation with Ph2SO/Tf2O of donor 24, the undesired fused bicycle 26 was formed. This side reaction makes these per‐O‐benzylated caryophyllose donors unsuitable for efficient glycosylation reactions. C) Conformational energy landscape (CEL) maps of selected pyranosyl oxocarbenium ions in which the found local minima are indicated with their respective energy. All energies are as computed at PCM(CH2Cl2)‐B3LYP/6–311G(d,p) at T=213.15 K and expressed as solution‐phase Gibbs free energy.

Cyclization reactions on activated glycosyl donors have been reported before (for example from a C6‐OBn to form a 1,6‐anhydrosugar), [48] but the rate with which the caryophyllose/yersiniose cyclization takes place is striking. Apparently, the architecture in these systems is intrinsically geared for this intramolecular nucleophilic cyclization. To prevent this cyclization, the C7‐OH was tethered to the C4‐OH, by the use of a carbonate protection group. Activation of the thus obtained donor 4, using the conditions described above, resulted in the formation of several species, amongst which the anomeric β‐oxosulfonium triflate 27 species (1H: δ 5.8 ppm; 13C: δ 107.6 ppm) as the dominant reactive intermediate (±80 % based on 1H‐NMR). To support that this is indeed the oxosulfonium triflate, more Ph2SO (+1.7 equiv.) was added after the activation, which led to the increase of the oxosulfonium signals and the disappearance of the signals corresponding to the anomeric triflate. Upon slow warming of the mixture, this species gradually converted into the anomeric α‐triflate and α‐oxosulfonium triflate species (See SI for all variable‐T NMR results).

To study the reactive intermediates on the other side of the reaction mechanism continuum, we studied the caryophyllose and yersiniose oxocarbenium ions by the use of DFT computations. We recently developed a DFT protocol to compute the relative energy of all possible glycopyranosyl oxocarbenium ion conformers, filling the complete conformational space these ions can occupy generating conformational energy landscape (CEL) maps.[ 49 , 50 , 51 ] Based on these CEL maps, a prediction can be made on the stereochemical outcome of reactions involving these ions. Figure 2 C shows the CEL maps of the two YerA oxocarbenium ions (these were selected as the substituted C6‐chain of caryophyllose would demand a significant increase in computing cost). The lowest energy structures are shown next to the CEL maps with their corresponding energy (with the lowest energy depicted in black/purple). The CEL map of oxocarbenium ion I (Figure 2 C, left) shows that this species preferentially takes up a 4 H 3 conformation. A second local minimum was found on the other side of the CEL map, revealing the B 1,4 conformer to be only slightly higher in energy (ΔG CH2Cl2 =0.5 kcal mol−1). This latter conformer explains the rapid formation of the bicycles found upon activation of donors 24 and 25 as the C7 ether is perfectly positioned to attack the C1 position in this cation. The CEL map of oxocarbenium ion II (Figure 2 C, right) reveals a single minimal energy conformer. This 4 H 3 conformer is preferentially attacked from the diastereotopic face that leads to a chair‐like transition state, and thus based on this analysis this cation is predicted to serve as a 1,2‐cis‐selective glycosylating species.

We next probed the donors 4 and 23 for their stereoselectivity in glycosylation reactions (Table 1). To this end, we performed a matrix of glycosylation reactions with a set of model alcohol nucleophiles of gradually decreasing nucleophilicity.[ 52 , 53 ] The trends observed relate to changes from an SN2‐type substitution reaction of the covalent intermediate for the most nucleophilic alcohols (EtOH and MFE), to reactions involving more oxocarbenium character (for the poorest nucleophiles; TFE, HFIP and TES‐d). The outcome of the glycosylation reactions for both the caryophyllose and yersiniose donor show clear trends with changing nucleophilicity of the used acceptors. The caryophyllose donor 4 and yersiniose donor 23 behave very similarly and with decreasing nucleophilicity the 1,2‐cis‐selectivity increases for both systems. Even with strong nucleophiles, somewhat more of the 1,2‐cis‐product is formed, which may be explained by the direct displacement of the β‐oxosulfonium triflate 27 species. The increasing 1,2‐cis‐selectivity can be accounted for by an increase of SN1 character in the glycosylation reaction, as the weaker nucleophiles require a more electrophilic glycosylating agent. The CEL maps revealed the 4 H 3 oxocarbenium ion conformers to be most stable and a stereoselective addition to these ions can explain the formation of the α‐products.

Table 1.

Experimentally found stereoselectivities for model glycosylation reactions with ethanol, 2‐fluoroethanol, 2,2‐difluoroethanol, 2,2,2‐trifluoroethanol, 1,1,1,3,3,3‐hexafluoro‐2‐propanol, triethylsilane‐d, 3‐butene‐1‐ol, 28, and 29. The stereoselectivity of the reaction is expressed as 1,2‐cis:1,2‐trans and based on the 1H‐NMR spectroscopy. The isolated yield of the glycosylation is given in parentheses. Experimental conditions: pre‐activation based glycosylation conditions; Ph2SO (1.3 equiv.), TTBP (2.5 equiv.), DCM (0.05 M), then Tf2O (1.3 equiv.), then nucleophile (2 equiv.), −80 °C to −60 °C.

graphic file with name ANIE-60-937-g005.jpg

graphic file with name ANIE-60-937-g006.jpg

graphic file with name ANIE-60-937-g007.jpg

67:33

(94 %)

50:50

(60 %)

graphic file with name ANIE-60-937-g008.jpg

83:17

(100 %)

66:34

(76 %)

graphic file with name ANIE-60-937-g009.jpg

87:13

(63 %)

80:20

(100 %)

graphic file with name ANIE-60-937-g010.jpg

>98:2

(76 %)

>98:2

(77 %)

graphic file with name ANIE-60-937-g011.jpg

>98:2

(16 %)

>98:2

(28 %)

graphic file with name ANIE-60-937-g012.jpg

donor

hydrolysis

>98:2

(54 %)

graphic file with name ANIE-60-937-g013.jpg

63:37

(97 %)

59:41

(86 %)

graphic file with name ANIE-60-937-g014.jpg

77:23

(50 %)

61:39

(63 %)

graphic file with name ANIE-60-937-g015.jpg

>98:2

(54 %)

>98:2

(74 %)

To evaluate nucleophiles relevant for the assembly of LOS IV‐fragment 1, three acceptors (3‐butene‐1‐ol, 28, and 29) were probed. Acceptors 28 and 29 represent truncated versions of the caryophyllose acceptor, and 3‐butene‐1‐ol will be used to serve as a conjugation‐ready linker moiety. Acceptor 28 is protected with benzyl groups, known to be electronically neutral, while 29 is protected with an electron‐withdrawing carbonate group. The difference in reactivity between these two acceptors is mirrored in the stereoselectivity of the glycosylation reactions with donors 4 and 23, with the more nucleophilic dibenzylated alcohol 28 providing an α/β‐mixture, while the less nucleophilic alcohol 29, exclusively formed the 1,2‐cis‐product. These results indicate the need for an electron‐withdrawing protecting group on the caryophyllose building block, when employed as an acceptor. The cyclic carbonate spanning hydroxyl groups at C10 and C11 in the synthesized caryophyllose building blocks thus serves this purpose.

After having established the glycosylation properties of the donors, we undertook the construction of the target Car‐Car‐NAcFuc LOS‐IV fragment 1 from building blocks 2, 3, and 4 (Figure 3 A). Because of the high reactivity of 3‐butene‐1‐ol, we sought to modify the reactivity of the reactive intermediates formed upon activation of the donor glycoside. To this end we turned to the use of an additive‐mediated glycosylation strategy. Various strategies have recently been developed to use exogenous nucleophiles to generate reactive intermediates of which the reactivity can be tuned to match the reactivity of the nucleophile that is to be glycosylated. Based on the work of Mukaiyama and co‐workers,[ 54 , 55 , 56 , 57 ] and others, [58] we have introduced triphenylphosphine oxide (TPPO) [59] to modulate the reactivity of anomeric iodides, in which the anomeric α‐iodide serves as a reservoir for the more reactive β‐iodide (or β‐phosphoniumiodide), which is the actual glycosylating species (See SI for the complete reactivity–selectivity mapping study with additives). Thus, caryophyllose 4 was pre‐activated in the usual manner, after which a mixture of tetrabutylammonium iodide and TPPO was added, and subsequently 3‐butene‐1‐ol was added. This led to the generation of spacer‐equipped caryophyllose 30 in 60 % yield and excellent stereoselectivity (>98:2; cis:trans). Subsequent HCl‐mediated deprotection of the 2‐methylnaphthyl protection group yielded caryophyllose acceptor 31 (61 %). [60] Coupling of this acceptor with donor 4 using pre‐activation conditions afforded disaccharide 32 in 50 % yield and with complete 1,2‐cis‐selectivity, in line with the results obtained with the model acceptor. Deprotection of the 2‐methylnaphthyl protection group of Car‐Car 32 required more acid compared to the deprotection of 30, because of the presence of more Lewis basic entities in the substrate, but furnished acceptor 33 in a similar yield (60 %). Coupling of acceptor 33 to 4‐azidofucose donor 3 under pre‐activation conditions provided 32 in 43 % yield with the exclusive formation of the 1,2‐cis‐product (See SI for the complete reactivity–selectivity mapping study performed with this donor). A Staudinger reduction was used to generate the free amine. Surprisingly, this transformation proceeded very sluggishly (reduction of the 4‐azido fucose monosaccharide proceeded readily with TPP in 79 % yield, see SI) even with the more reactive trimethyl phosphine. The crude product was directly coupled to the pyrrolidone 2, to yield the completely protected Car‐Car‐NAcFuc LOS‐IV fragment 35. Deprotection was done by saponification of the carbonate protection groups and the benzyl ester on the pyrrolidone, followed by debenzylation under Birch condition, to successfully yield the target structure 1 in 40 % yield over the two deprotection steps.

Figure 3.

Figure 3

A) Assembly of LOS‐IV fragment 1. Reagents and conditions: (1) Ph2SO, TTBP, N‐ethyl maleimide, then Tf2O, then TBAI, TPPO, then 3‐buten‐1‐ol, −80 °C to 40 °C (60 %); (2) HCl/HFIP, TES, DCM (61 %); (3) Ph2SO, TTBP, DCM, then Tf2O, then 31, −80 °C to −60 °C (50 %); (4) HCl/HFIP, TES, DCM (60 %); (5) Ph2SO, TTBP, DCM, then Tf2O, then 33, −80 °C to −60 °C (43 %); (6) i. trimethylphosphine, THF ii. 2, TEA, HATU, CH3CN (15 % over 2 steps); (7) i. LiOH, H2O, THF ii. Na, NH3, t‐BuOH, THF (40 % over 2 steps). Tf2O=trifluoromethanesulfonic anhydride, TTBP=2,4,6‐tri‐t‐butylpyrimidine, TBAI=t‐butylammonium iodide, TPPO=triphenylphosphine oxide, HFIP=hexafluorisopropanol, TES=triethylsilane, HATU=1‐[bis(dimethylamino)methylene]‐1H‐1,2,3‐triazolo[4,5‐b]pyridinium 3‐oxide hexafluorophosphate, TEA=triethylamine. B) 1H‐13C HSQC NMR overlay of the acidic OS‐IV fraction isolated by Rombouts et al. [12] (red=residues of the natural product present in the synthesized fragment 1, and grey=residues absent of the natural product in the synthesized fragment 1, and blue=synthesized compound 1). I to IX correspond to the nine monosaccharides of the OS‐IV. In the overlay most signals overlap. Only signals close to the linker on VII are slightly off, because this area is different from the natural compound, which is linked to a xylose.

The structure and purity of compound 1, were confirmed by NMR and HRMS analysis. It was observed that 1 exists as a mixture of atropisomers [61] , in line with the behavior of related pyrrolidone‐4‐aminofucose monosaccharides, prepared by Lowary and co‐workers. [38] Figure 3 B compares the 1H‐13C HSQC NMR spectra of the synthetic LOS‐IV fragment 1 with the natural product, isolated by Rombouts et al. [12] The blue signals originate from the synthesized compound, the red signals are from the natural product, and all residues from the natural product that are absent in the synthetic fragment are grey. From the overlay it is apparent that the spectra closely match, indicating that the assembled fragment resembles the natural product very well.

Conclusion

In conclusion, we have reported a systematic evaluation of the reactivity of tertiary‐C sugar building blocks, caryophyllose and yersiniose. An approach, consisting of a systematic series of glycosylation reactions in combination with the detection and characterization of different reactive intermediates using variable‐T NMR and conformational energy landscape computations, were used to assess reactivity–stereoselectivity relationships. We found for these 4‐C‐branched sugars that ether functionalities in the appended side‐chain readily attack the activated anomeric center of the caryophyllose and yersiniose donors, leading to unproductive glycosylation reactions. This behavior has been explained using the conformational preference of oxocarbenium ion intermediates that can form. Prevention of this nucleophilic attack is a prerequisite to generate effective donor glycosides and could be achieved by tethering of the C4 side‐chain. We found that tethered Car and YerA donors can efficiently form the desired 1,2‐cis linkages, as long as weak nucleophiles are employed in the glycosylation. In order to achieve 1,2‐cis‐selectivity, the reactivity of the Car‐acceptors was tuned using electron‐withdrawing protecting groups. The rationally designed building blocks enabled the first effective and stereoselective assembly of a Car‐Car‐NAcFuc LOS‐IV fragment, and related shorter fragments. The approach taken here can be used to uncover the reactivity of rare bacterial saccharides. The insight gathered will be a solid base to inform future syntheses of bacterial oligosaccharides and glycoconjugates to fuel immunological‐ and biological research.

Conflict of interest

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary

Acknowledgements

Quantum chemical calculations were performed at the SurfSARA HPC center in Amsterdam; access was provided via NWO‐Rekentijd grant 17569 (to T.H. and J.D.C.C.). This work was supported by an ERC‐CoG (726072) and NWO VICI (VI.C.182.020) grant awarded to J.D.C.C. We kindly acknowledge Mark Somers for technical support.

T. Hansen, T. P. Ofman, J. G. C. Vlaming, I. A. Gagarinov, J. van Beek, T. A. Goté, J. M. Tichem, G. Ruijgrok, H. S. Overkleeft, D. V. Filippov, G. A. van der Marel, J. D. C. Codée, Angew. Chem. Int. Ed. 2021, 60, 937.

References

  • 1. Tytgat H. L. P., Lebeer S., Microbiol. Mol. Biol. Rev. 2014, 78, 372–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Herget S., Toukach P. V., Ranzinger R., Hull W. E., Knirel Y. A., von der Lieth C.-W., BMC Struct. Biol. 2008, 8, 35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Elshahawi S. I., Shaaban K. A., Kharel M. K., Thorson J. S., Chem. Soc. Rev. 2015, 44, 7591–7697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Thibodeaux C. J., Melançon C. E., Liu H., Angew. Chem. Int. Ed. 2008, 47, 9814–9859; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2008, 120, 9960–10007. [Google Scholar]
  • 5. Thibodeaux C. J., Melançon C. E., Liu H., Nature 2007, 446, 1008–1016. [DOI] [PubMed] [Google Scholar]
  • 6. Werz D. B., Ranzinger R., Herget S., Adibekian A., von der Lieth C.-W., Seeberger P. H., ACS Chem. Biol. 2007, 2, 685–691. [DOI] [PubMed] [Google Scholar]
  • 7. Zeng J., Sun G., Yao W., Zhu Y., Wang R., Cai L., Liu K., Zhang Q., Liu X.-W., Wan Q., Angew. Chem. Int. Ed. 2017, 56, 5227–5231; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 5311–5315. [Google Scholar]
  • 8. Bera S., Chatterjee B., Mondal D., RSC Adv. 2016, 6, 77212–77242. [Google Scholar]
  • 9. Wang S., Sun J., Zhang Q., Cao X., Zhao Y., Tang G., Yu B., Angew. Chem. Int. Ed. 2018, 57, 2884–2888; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 2934–2938. [Google Scholar]
  • 10. Nicolaou K. C., Renaud J., Nantermet P. G., Couladouros E. A., Guy R. K., Wrasidlo W., J. Am. Chem. Soc. 1995, 117, 2409–2420. [Google Scholar]
  • 11. Rombouts Y., Burguière A., Maes E., Coddeville B., Elass E., Guérardel Y., Kremer L., J. Biol. Chem. 2009, 284, 20975–20988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Rombouts Y., Elass E., Biot C., Maes E., Coddeville B., Burguière A., Tokarski C., Buisine E., Trivelli X., Kremer L., Guérardel Y., J. Am. Chem. Soc. 2010, 132, 16073–16084. [DOI] [PubMed] [Google Scholar]
  • 13. Rombouts Y., Alibaud L., Carrère-Kremer S., Maes E., Tokarski C., Elass E., Kremer L., Guérardel Y., J. Biol. Chem. 2011, 286, 33678–33688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lowary T. L., Acc. Chem. Res. 2016, 49, 1379–1388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Bai B., Chu C., Lowary T. L., Isr. J. Chem. 2015, 55, 360–372. [Google Scholar]
  • 16. Nobre A., Alarico S., Maranha A., Mendes V., Empadinhas N., Microbiology 2014, 160, 1547–1570. [DOI] [PubMed] [Google Scholar]
  • 17. Burguière A., Hitchen P. G., Dover L. G., Kremer L., Ridell M., Alexander D. C., Liu J., Morris H. R., Minnikin D. E., Dell A., Besra G. S., J. Biol. Chem. 2005, 280, 42124–42133. [DOI] [PubMed] [Google Scholar]
  • 18. Ren H., Dover L. G., Islam S. T., Alexander D. C., Chen J. M., Besra G. S., Liu J., Mol. Microbiol. 2007, 63, 1345–1359. [DOI] [PubMed] [Google Scholar]
  • 19. Sarkar D., Sidhu M., Singh A., Chen J., Lammas D. A., van der Sar A. M., Besra G. S., Bhatt A., J. Bacteriol. 2011, 193, 2336–2340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Nigudkar S. S., Demchenko A. V., Chem. Sci. 2015, 6, 2687–2704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Demchenko A. V. in Handbook of Chemical Glycosylation (Ed.: Demchenko A. V.), Wiley-VCH, Weinheim, 2008, pp. 1–27. [Google Scholar]
  • 22. Adero P. O., Amarasekara H., Wen P., Bohé L., Crich D., Chem. Rev. 2018, 118, 8242–8284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hahm H. S., Hurevich M., Seeberger P. H., Nat. Commun. 2016, 7, 12482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Mensink R. A., Boltje T. J., Chem. Eur. J. 2017, 23, 17637–17653. [DOI] [PubMed] [Google Scholar]
  • 25. Leng W.-L., Yao H., He J.-X., Liu X.-W., Acc. Chem. Res. 2018, 51, 628–639. [DOI] [PubMed] [Google Scholar]
  • 26. Wang C.-C., Lee J.-C., Luo S.-Y., Kulkarni S. S., Huang Y.-W., Lee C.-C., Chang K.-L., Hung S.-C., Nature 2007, 446, 896–899. [DOI] [PubMed] [Google Scholar]
  • 27. Zhu X., Schmidt R. R., Angew. Chem. Int. Ed. 2009, 48, 1900–1934; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2009, 121, 1932–1967. [Google Scholar]
  • 28. van der Vorm S., Hansen T., van Hengst J. M. A., Overkleeft H. S., van der Marel G. A., Codée J. D. C., Chem. Soc. Rev. 2019, 48, 4688–4706. [DOI] [PubMed] [Google Scholar]
  • 29. Hansen T., Elferink H., van Hengst J. M. A., Houthuijs K. J., Remmerswaal W. A., Kromm A., Berden G., van der Vorm S., Rijs A. M., Overkleeft H. S., Filippov D. V., Rutjes F. P. J. T., van der Marel G. A., Martens J., Oomens J., Codée J. D. C., Boltje T. J., Nat. Commun. 2020, 11, 2664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Liu H., Hansen T., Zhou S.-Y., Wen G.-E., Liu X.-X., Zhang Q.-J., Codée J. D. C., Schmidt R. R., Sun J.-S., Org. Lett. 2019, 21, 8713–8717. [DOI] [PubMed] [Google Scholar]
  • 31. Hagen B., van der Vorm S., Hansen T., van der Marel G. A., Codée J. D. C. in Selective Glycosylations: Synthetic Methods and Catalysts (Ed.: Bennett C. S.), Wiley-VCH, Weinheim, 2017, pp. 1–28. [Google Scholar]
  • 32. Bohé L., Crich D., Carbohydr. Res. 2015, 403, 48–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Zhang Q., Gimeno A., Santana D., Wang Z., Valdés-Balbin Y., Rodríguez-Noda L. M., Hansen T., Kong L., Shen M., Overkleeft H. S., Vérez-Bencomo V., van der Marel G. A., Jiménez-Barbero J., Chiodo F., Codée J. D. C., ACS Cent. Sci. 2019, 5, 1407–1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Crich D., Acc. Chem. Res. 2010, 43, 1144–1153. [DOI] [PubMed] [Google Scholar]
  • 35. Mydock L. K., Demchenko A. V., Org. Biomol. Chem. 2010, 8, 497–510. [DOI] [PubMed] [Google Scholar]
  • 36. Seeberger P. H., Werz D. B., Nature 2007, 446, 1046–1051. [DOI] [PubMed] [Google Scholar]
  • 37. Marianski M., Mucha E., Greis K., Moon S., Pardo A., Kirschbaum C., Thomas D. A., Meijer G., von Helden G., Gilmore K., Seeberger P. H., Pagel K., Angew. Chem. Int. Ed. 2020, 59, 6166–6171; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2020, 132, 6224–6229. [Google Scholar]
  • 38. Wang L., Dong M., Lowary T. L., J. Org. Chem. 2015, 80, 2767–2780. [DOI] [PubMed] [Google Scholar]
  • 39. Prandi J., Carbohydr. Res. 2001, 332, 241–247. [DOI] [PubMed] [Google Scholar]
  • 40. Prandi J., Couturier G., Tetrahedron Lett. 2000, 41, 49–52. [Google Scholar]
  • 41. Guiard J., Rahali Y., Praly J.-P., Eur. J. Org. Chem. 2014, 4461–4466. [Google Scholar]
  • 42. Frihed T. G., Bols M., Pedersen C. M., Chem. Rev. 2015, 115, 4963–5013. [DOI] [PubMed] [Google Scholar]
  • 43. Codée J. D. C., Litjens R. E. J. N., den Heeten R., Overkleeft H. S., van Boom J. H., van der Marel G. A., Org. Lett. 2003, 5, 1519–1522. [DOI] [PubMed] [Google Scholar]
  • 44. Hagen B., Ali S., Overkleeft H. S., van der Marel G. A., Codée J. D. C., J. Org. Chem. 2017, 82, 848–868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. van der Vorm S., Overkleeft H. S., van der Marel G. A., Codée J. D. C., J. Org. Chem. 2017, 82, 4793–4811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Crich D., Cai W., J. Org. Chem. 1999, 64, 4926–4930. [DOI] [PubMed] [Google Scholar]
  • 47. Crich D., Sun S., J. Am. Chem. Soc. 1997, 119, 11217–11223. [Google Scholar]
  • 48. Christensen H. M., Oscarson S., Jensen H. H., Carbohydr. Res. 2015, 408, 51–95. [DOI] [PubMed] [Google Scholar]
  • 49. Hansen T., Lebedel L., Remmerswaal W. A., van der Vorm S., Wander D. P. A., Somers M., Overkleeft H. S., Filippov D. V., Désiré J., Mingot A., Bleriot Y., van der Marel G. A., Thibaudeau S., Codée J. D. C., ACS Cent. Sci. 2019, 5, 781–788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. van der Vorm S., Hansen T., van Rijssel E. R., Dekkers R., Madern J. M., Overkleeft H. S., Filippov D. V., van der Marel G. A., Codée J. D. C., Chem. Eur. J. 2019, 25, 7149–7157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Madern J. M., Hansen T., van Rijssel E. R., Kistemaker H. A. V., van der Vorm S., Overkleeft H. S., van der Marel G. A., Filippov D. V., Codée J. D. C., J. Org. Chem. 2019, 84, 1218–1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. van der Vorm S., Hansen T., Overkleeft H. S., van der Marel G. A., Codée J. D. C., Chem. Sci. 2017, 8, 1867–1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Beaver M. G., Woerpel K. A., J. Org. Chem. 2010, 75, 1107–1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Mukaiyama T., Kobashi Y., Shintou T., Chem. Lett. 2003, 32, 900–901. [Google Scholar]
  • 55. Mukaiyama T., Kobashi Y., Chem. Lett. 2004, 33, 10–11. [Google Scholar]
  • 56. Kobashi Y., Mukaiyama T., Bull. Chem. Soc. Jpn. 2005, 78, 910–916. [Google Scholar]
  • 57. Kobashi Y., Mukaiyama T., Chem. Lett. 2004, 33, 874–875. [Google Scholar]
  • 58. Chu A.-H. A., Nguyen S. H., Sisel J. A., Minciunescu A., Bennett C. S., Org. Lett. 2013, 15, 2566–2569. [DOI] [PubMed] [Google Scholar]
  • 59. Wang L., Overkleeft H. S., van der Marel G. A., Codée J. D. C., J. Am. Chem. Soc. 2018, 140, 4632–4638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Volbeda A. G., Kistemaker H. A. V., Overkleeft H. S., van der Marel G. A., Filippov D. V., Codée J. D. C., J. Org. Chem. 2015, 80, 8796–8806. [DOI] [PubMed] [Google Scholar]
  • 61. Reisberg S. H., Gao Y., Walker A. S., Helfrich E. J. N., Clardy J., Baran P. S., Science 2020, 367, 458–463. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES